Abstract
Since the discovery of endothelin in vascular endothelial cells and its pivotal role in vascular physiology (Yanagisawa and colleagues [1]), a number of studies have focused on the localisation of this vasoconstrictor peptide in human and animal vascular tissue, largely in endothelial cells. Various vascular beds have been the subject of research in normal and pathophysiological conditions, for example in neonates, during ageing, pregnancy, hypertension, diabetes, heart failure, experimental metastases and neurological disorders. These studies have revealed the presence of endothelin in the blood vessel wall, suggesting the involvement of this peptide in vascular physiology in health and disease. This chapter reviews studies on the distribution of endothelin-1 (ET-1) and its receptors (ETA and ETB) in vascular tissue with emphasis on their ultrastructural localisation.
Keywords: endothelin, endothelin receptors, immunocytochemical localisation, vascular tissue, ultrastructure
Current Vascular Pharmacology
Title: Localisation of Endothelin-1 and its Receptors in Vascular Tissue as Seen at the Electron Microscopic Level
Volume: 3 Issue: 4
Author(s): Andrzej Loesch
Affiliation:
Keywords: endothelin, endothelin receptors, immunocytochemical localisation, vascular tissue, ultrastructure
Abstract: Since the discovery of endothelin in vascular endothelial cells and its pivotal role in vascular physiology (Yanagisawa and colleagues [1]), a number of studies have focused on the localisation of this vasoconstrictor peptide in human and animal vascular tissue, largely in endothelial cells. Various vascular beds have been the subject of research in normal and pathophysiological conditions, for example in neonates, during ageing, pregnancy, hypertension, diabetes, heart failure, experimental metastases and neurological disorders. These studies have revealed the presence of endothelin in the blood vessel wall, suggesting the involvement of this peptide in vascular physiology in health and disease. This chapter reviews studies on the distribution of endothelin-1 (ET-1) and its receptors (ETA and ETB) in vascular tissue with emphasis on their ultrastructural localisation.
Export Options
About this article
Cite this article as:
Loesch Andrzej, Localisation of Endothelin-1 and its Receptors in Vascular Tissue as Seen at the Electron Microscopic Level, Current Vascular Pharmacology 2005; 3 (4) . https://dx.doi.org/10.2174/157016105774329381
DOI https://dx.doi.org/10.2174/157016105774329381 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association Between Hypothyroidism and Takotsubo Cardiomyopathy: Analysis of Nationwide Inpatient Sample Database
Reviews on Recent Clinical Trials Herb-Drug Interactions: An Insight into Cardiovascular Diseases Based on Case Reports
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial (Hot Topic: Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon)
Current Pharmaceutical Design Novel Therapies Targeting Cardioprotection and Regeneration
Current Pharmaceutical Design Strategic Leukofiltration in Cardiac Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Double-Edged Effects of Arsenic Compounds: Anticancer and Carcinogenic Effects
Current Drug Metabolism Novel Ideas of Gene Therapy for Atherosclerosis: Modulation of Cellular Signal Transduction of TGF-β Family
Current Pharmaceutical Design Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Recent Patents on Drug Delivery & Formulation Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Current Pharmaceutical Design A Review of Clinical Pharmacokinetics and Pharmacodynamics of Galantamine, a Reversible Acetylcholinesterase Inhibitor for the Treatment of Alzheimer s Disease, in Healthy Subjects and Patients
Current Clinical Pharmacology Glucose Control and Use of Continuous Glucose Monitoring in the Intensive Care Unit: A Critical Review
Current Diabetes Reviews Novel Antithrombotic Agents: Indirect Synthetic Inhibitors of Factor Xa and Direct Thrombin Inhibitors. Evidences from Clinical Studies
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Management of Blood Pressure and Heart Rate in Acute Decompensated Heart Failure with Volume Overload
Current Pharmaceutical Design Gender-Specific Aspects in Primary and Secondary Prevention of Cardiovascular Disease
Current Pharmaceutical Design MRI of Pancreas in Patients with Chronic Pancreatitis and Healthy Volunteers: Can Pancreatic Signal Intensity and Contrast Enhancement Patterns be Valuable Predictors of Early Chronic Pancreatitis?
Current Medical Imaging Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Current Proteomics Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies)
Current Pharmaceutical Design The Adenine Nucleotide Translocase 2, a Mitochondrial Target for Anticancer Biotherapy
Current Drug Targets Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide
Current Topics in Medicinal Chemistry Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Current Topics in Medicinal Chemistry